Aras A - Search Results

1

Evaluation of unusual and highly aggressive variant of endometrium cancer: nonendometrioid endometrium carcinoma of the uterus.

Sert F, Yılmaz U, Alanyalı S, Aras A, Ozsaran Z. Sert F, et al. Among authors: aras a. Tumori. 2017 Nov 23;103(6):551-556. doi: 10.5301/tj.5000404. Epub 2015 Sep 17. Tumori. 2017. PMID: 26391760

2

The interaction between antioxidant status and cervical cancer: a case control study.

Demirci S, Ozsaran Z, Celik HA, Aras AB, Aydin HH. Demirci S, et al. Tumori. 2011 May-Jun;97(3):290-5. doi: 10.1177/030089161109700306. Tumori. 2011. PMID: 21789005

3

Adjuvant radiotherapy for uterine carcinosarcoma: A retrospective assessment of treatment outcomes.

Yilmaz U, Alanyali S, Aras AB, Ozsaran Z. Yilmaz U, et al. J Cancer Res Ther. 2019 Oct-Dec;15(6):1377-1382. doi: 10.4103/jcrt.JCRT_531_18. J Cancer Res Ther. 2019. PMID: 31898676 Free article.

4

Treatment results and prognostic factors of patients with vulvar cancer treated with postoperative or definitive radiotherapy.

Alanyali S, Duran Ö, Özsaran Z, Özsaran A, Akman L, Solmaz U, Gökçü M, Sanci M, Aras AB. Alanyali S, et al. Among authors: aras ab. Tumori. 2016 Jun 2;2016(3):311-5. doi: 10.5301/tj.5000509. Epub 2016 Apr 14. Tumori. 2016. PMID: 27079905

5

Quality of life assessment in women with breast cancer: a prospective study including hormonal therapy.

Sert F, Ozsaran Z, Eser E, Alanyalı SD, Haydaroglu A, Aras A. Sert F, et al. Among authors: aras a. J Breast Cancer. 2013 Jun;16(2):220-8. doi: 10.4048/jbc.2013.16.2.220. Epub 2013 Jun 28. J Breast Cancer. 2013. PMID: 23843857 Free PMC article.

6

Adverse effects of endocrine therapy in breast cancer: single institute experience.

Sert F, Ozsaran Z, Esen E, Alanyalı S, Sert I, Haydaoglu A, Aras A. Sert F, et al. Among authors: aras a. Contemp Oncol (Pozn). 2014;18(5):344-8. doi: 10.5114/wo.2014.45245. Epub 2014 Nov 5. Contemp Oncol (Pozn). 2014. PMID: 25477758 Free PMC article.

7

Treatment results and prognostic factors for cervical cancer patients treated by radiochemotherapy with weekly cisplatin.

Ozsaran Z, Kamer S, Yalman D, Akagunduz O, Aras A. Ozsaran Z, et al. Among authors: aras a. Eur J Gynaecol Oncol. 2007;28(3):196-200. Eur J Gynaecol Oncol. 2007. PMID: 17624086

8

Results of postoperative radiotherapy in the treatment of uterine sarcomas: a retrospective analysis of 46 patients.

Yalman D, Ozsaran Z, Baltalarli B, Demir O, Ozdemir N, Aras A. Yalman D, et al. Among authors: aras a. Eur J Gynaecol Oncol. 2008;29(1):46-51. Eur J Gynaecol Oncol. 2008. PMID: 18386463

9

Evaluation of acute and late radiation morbidity in patients with gynaecologic malignancy using the RTOG criteria and Franco-Italian glossary.

Yildirim G, Ozsaran Z, Yalman D, Kamer S, Aras A. Yildirim G, et al. Among authors: aras a. Eur J Gynaecol Oncol. 2008;29(2):154-7. Eur J Gynaecol Oncol. 2008. PMID: 18459551

10

Postoperative radiotherapy in intermediate and high-risk Stage I endometrial cancer: analysis of prognostic factors and survival.

Bolukbasi Y, Demirci S, Ozsaran Z, Yalman D, Hanhan M, Ozsaran A, Dikmen Y, Aras A. Bolukbasi Y, et al. Among authors: aras a. Eur J Gynaecol Oncol. 2008;29(5):505-10. Eur J Gynaecol Oncol. 2008. PMID: 19051823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters